GLP-1 medications are more popular than ever, as science continues to discover new ways they can be used to address a variety of health conditionsfrom managing type 2 diabetes and obesity to reducing addictive behaviors and even lowering your dementia risk
Retatrutide has shown superior liver fat reduction data approximately 82% mean reduction in hepatic fat content in Phase 2, driven by glucagon receptor-mediated stimulation of hepatic beta-oxidation
Providers assess each patients health history, skin type, and goals to determine the optimal dose, delivery method, and treatment frequency
In a head-to-head comparison, tirzepatide (first approved in 2022) has indeed performed better than semaglutide at treating obesity
ShapeScale provides over 20 localized measurements revealing if youre on track with your individual goals or if you need to readjust
In contrast, the induction of EAE was associated with a predominance of T cells reactive to the 71-90 epitope